Drug Shortage Report for AURO-OLANZAPINE ODT
| Report ID | 56349 |
| Drug Identification Number | 02448742 |
| Brand name | AURO-OLANZAPINE ODT |
| Common or Proper name | OLANZAPINE |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OLANZAPINE |
| Strength(s) | 15MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL |
| Packaging size | 3X10 |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-07-25 |
| Estimated end date | 2022-02-10 |
| Actual end date | 2022-01-07 |
| Shortage status | Resolved |
| Updated date | 2022-02-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v41 | 2021-12-30 | English | Compare |
| v42 | 2021-12-30 | French | Compare |
| v43 | 2022-02-09 | English | Compare |
| v44 | 2022-02-09 | French | Compare |